Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia
Conditions:   Fanconi Anemia;   Myelodysplastic Syndrome (MDS);   Acute Myelogenous Leukemia (AML) Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Anti-Thymocyte Globulin (Rabbit);   Device: The CliniMACS device;   Drug: G-CSF Sponsors:   Memorial Sloan Kettering Cancer Center;   Pediatric Brain Tumor Consortium Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2018 Category: Research Source Type: clinical trials